Brian Allar
Family · Waterford, MINPI 1841813813
Payments from drug & device makers
Across 285 payments — averaging $17.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$630
- Merck$549
- AstraZeneca$524
- Johnson & Johnson$508
- Amgen$496
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$440
- plus $2K from 23 others
What the payments were for
- Consulting fees$150%
- Food & beverage$4,66293%
- Education$3246%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 39 | $630 |
| Merck | 33 | $549 |
| AstraZeneca | 28 | $524 |
| Johnson & Johnson | 33 | $508 |
| Amgen | 31 | $496 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 27 | $440 |
| E.r. Squibb & Sons, L.L.C. | 22 | $316 |
| Actelion Pharmaceuticals US, Inc. | 7 | $269 |
| Boehringer Ingelheim | 8 | $176 |
| Kiniksa Pharmaceuticals, Ltd. | 5 | $152 |
| Pfizer | 8 | $139 |
| Edwards Lifesciences | 5 | $101 |
| Boston Scientific | 6 | $85 |
| Baxter Healthcare | 3 | $77 |
| Alnylam Pharmaceuticals Inc. | 5 | $71 |
| Philips North America LLC | 3 | $67 |
| Sanofi-aventis U.S. LLC | 3 | $65 |
| Kestra Medical Technology Services, Inc. | 2 | $54 |
| Scpharmaceuticals Inc. | 3 | $51 |
| Novo Nordisk | 2 | $40 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $36 |
| Lexicon Pharmaceuticals, Inc. | 2 | $28 |
| Bardy Diagnostics, Inc. | 2 | $25 |
| Abiomed | 1 | $24 |
| Cordis US CORP. | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Medtronic | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$101
How this compares
$5,001 in reported general payments places this provider in the 90th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 191 | $238,876 |
| EntrestoSacubitril/Valsartan | 36 | $46,979 |
| JardianceEmpagliflozin | 22 | $33,680 |
| FarxigaDapagliflozin Propanediol | 22 | $28,732 |
| XareltoRivaroxaban | 15 | $20,588 |
| Repatha SureclickEvolocumab | 17 | $16,776 |
| VerquvoVericiguat | 11 | $6,916 |
| Ranolazine ErRanolazine | 27 | $2,853 |
| Metoprolol Succinate | 109 | $2,270 |
| Rosuvastatin Calcium | 92 | $1,887 |
| Atorvastatin Calcium | 81 | $1,237 |
| Losartan Potassium | 64 | $978 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 14 | $933 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 55 | $905 |
| ClopidogrelClopidogrel Bisulfate | 41 | $904 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $139 | $238,876191 claims |
| NovartisEntresto | $630 | $46,97936 claims |
| Boehringer IngelheimJardiance | $176 | $33,68022 claims |
| AstraZenecaFarxiga | $524 | $28,73222 claims |
| Johnson & JohnsonXarelto | $508 | $20,58815 claims |
| MerckVerquvo | $549 | $6,91611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,657 family providers in Michigan.
Other family in Waterford
- Kailey TempleWaterford$14K
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.